Caredx, Inc.
A precision medicine company focused on keeping transplanted organs healthy. CareDx makes non-invasive blood tests — AlloMap Heart and the AlloSure Kidney, Heart, and Lung panels — that monitor transplant recipients for early signs of rejection without a biopsy, along with HLA typing kits and AlloSeq gene-sequencing tools used to match donors and recipients. Its Ottr and MedActionPlan software help transplant teams track and manage patient care between visits.
Granted 270.1K · Sold 124.4K
Granted 98.6K
Granted 41.5K
Granted 71.6K
Granted 9.8K
Granted 38.9K
Granted 37.3K · Sold 17.1K
Granted 40.9K
Granted 9.8K
Granted 9.8K
Sold 10.6K
Granted 37.2K
Granted 9.8K · Sold 12.1K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Hanna John Walter JRPresident and CEO, Director · 19 transactions | +5.6% | 662.0K | 270.1K | — | 124.4K |
| Kennedy KeithCFO & COO · 6 transactions | +50.4% | 221.5K | 98.6K | — | — |
| Goldberg MichaelDirector · 7 transactions | +26.9% | 195.7K | 41.5K | — | — |
| Meng JessicaChief Commercial Officer · 5 transactions | +48.2% | 169.4K | 71.6K | — | — |
| Cohen Fred EDirector · 1 transaction | +6.3% | 165.1K | 9.8K | — | — |
| Bickerstaff GeorgeDirector · 2 transactions | +33.8% | 154.1K | 38.9K | — | — |
| Novack Jeffrey AdamSecretary and General Counsel · 15 transactions | -0.3% | 112.6K | 37.3K | — | 17.1K |
| Smith NathanChief Financial Officer · 3 transactions | +78.6% | 75.0K | 40.9K | — | — |
| Cournoyer ChristineDirector · 1 transaction | +19.9% | 58.9K | 9.8K | — | — |
| Riggsbee Richard BryanDirector · 1 transaction | +33.2% | 39.3K | 9.8K | — | — |
| Torres Arthur ADirector · 2 transactions | -21.5% | 38.7K | — | — | 10.6K |
| Gunasekaran SureshDirector · 2 transactions | — | 37.2K | 37.2K | — | — |
| Valantine HannahDirector · 2 transactions | -5.9% | 36.7K | 9.8K | — | 12.1K |
Select a row to see that insider’s individual transactions.
Net open-market activity over the last year: -164.2K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.